US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 1.5800
  • +0.2100+15.33%
Close Apr 23 16:00 ET
  • 1.5500
  • -0.0300-1.90%
Post 17:27 ET
10.23MMarket Cap-442P/E (TTM)

Inhibikase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.82%20.09M
1.58%4.4M
5.67%4.77M
33.67%6.2M
1.60%4.71M
22.77%18.13M
-14.01%4.33M
0.94%4.51M
76.53%4.64M
76.77%4.64M
Selling and administrative expenses
8.28%6.73M
4.18%1.4M
5.47%1.62M
7.14%1.78M
15.32%1.93M
-4.47%6.22M
-18.68%1.34M
-6.46%1.54M
3.44%1.66M
4.31%1.67M
Research and development costs
13.16%13.62M
-1.68%3M
8.18%3.23M
52.09%4.54M
-5.40%2.85M
5.95%12.03M
-9.91%3.05M
-5.48%2.98M
25.17%2.98M
24.06%3.02M
Other operating expenses
-111.03%-260.5K
100.00%-1
-991.33%-79.57K
-1,676.71%-116.41K
-40.17%-64.52K
96.02%-123.44K
-3,169.86%-63.57K
97.78%-7.29K
99.52%-6.55K
96.73%-46.03K
Operating profit
-10.82%-20.09M
-1.58%-4.4M
-5.67%-4.77M
-33.67%-6.2M
-1.60%-4.71M
-22.77%-18.13M
14.01%-4.33M
-0.94%-4.51M
-76.53%-4.64M
-76.77%-4.64M
Net non-operating interest income expense
1,324.94%1.06M
303.47%225.63K
836.97%173.68K
424.44K
4,743,520.00%237.17K
473.70%74.45K
35,493.67%55.92K
11,906.37%18.54K
0
99.96%-5
Non-operating interest income
1,324.94%1.06M
303.47%225.63K
836.97%173.68K
----
----
--74.45K
--55.92K
--18.54K
----
----
Total other finance cost
----
----
----
---424.44K
-4,743,520.00%-237.17K
----
----
----
----
--5
Other net income (expense)
Income before tax
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
Income tax
Net income
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
Net income continuous Operations
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
Minority interest income
Net income attributable to the parent company
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
Basic earnings per share
16.59%-3.57
37.25%-0.64
18.87%-0.86
-0.91%-1.11
11.11%-0.96
11.93%-4.28
15.00%-1.02
1.85%-1.06
16.67%-1.1
30.77%-1.08
Diluted earnings per share
16.59%-3.57
37.25%-0.64
18.87%-0.86
-0.91%-1.11
11.11%-0.96
11.93%-4.28
15.00%-1.02
1.85%-1.06
16.67%-1.1
30.77%-1.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.82%20.09M1.58%4.4M5.67%4.77M33.67%6.2M1.60%4.71M22.77%18.13M-14.01%4.33M0.94%4.51M76.53%4.64M76.77%4.64M
Selling and administrative expenses 8.28%6.73M4.18%1.4M5.47%1.62M7.14%1.78M15.32%1.93M-4.47%6.22M-18.68%1.34M-6.46%1.54M3.44%1.66M4.31%1.67M
Research and development costs 13.16%13.62M-1.68%3M8.18%3.23M52.09%4.54M-5.40%2.85M5.95%12.03M-9.91%3.05M-5.48%2.98M25.17%2.98M24.06%3.02M
Other operating expenses -111.03%-260.5K100.00%-1-991.33%-79.57K-1,676.71%-116.41K-40.17%-64.52K96.02%-123.44K-3,169.86%-63.57K97.78%-7.29K99.52%-6.55K96.73%-46.03K
Operating profit -10.82%-20.09M-1.58%-4.4M-5.67%-4.77M-33.67%-6.2M-1.60%-4.71M-22.77%-18.13M14.01%-4.33M-0.94%-4.51M-76.53%-4.64M-76.77%-4.64M
Net non-operating interest income expense 1,324.94%1.06M303.47%225.63K836.97%173.68K424.44K4,743,520.00%237.17K473.70%74.45K35,493.67%55.92K11,906.37%18.54K099.96%-5
Non-operating interest income 1,324.94%1.06M303.47%225.63K836.97%173.68K----------74.45K--55.92K--18.54K--------
Total other finance cost ---------------424.44K-4,743,520.00%-237.17K------------------5
Other net income (expense)
Income before tax -5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M-76.01%-4.64M-75.98%-4.64M
Income tax
Net income -5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M-76.01%-4.64M-75.98%-4.64M
Net income continuous Operations -5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M-76.01%-4.64M-75.98%-4.64M
Minority interest income
Net income attributable to the parent company -5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M-76.01%-4.64M-75.98%-4.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M-76.01%-4.64M-75.98%-4.64M
Basic earnings per share 16.59%-3.5737.25%-0.6418.87%-0.86-0.91%-1.1111.11%-0.9611.93%-4.2815.00%-1.021.85%-1.0616.67%-1.130.77%-1.08
Diluted earnings per share 16.59%-3.5737.25%-0.6418.87%-0.86-0.91%-1.1111.11%-0.9611.93%-4.2815.00%-1.021.85%-1.0616.67%-1.130.77%-1.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg